102. The palm is ~0.5% TBSA - Insurance companies denying coverage - Malignancy risk in JAK inhibitors - MACE risk in JAK inhibitors - Oral azoles for head-and-neck dermatitis

Dermasphere - The Dermatology Podcast

Innhold levert av Luke Johnson. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Luke Johnson eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

1+ y ago 1:00:36

MP3•Episoder hjem

The palm is ~0.5% TBSA -

Insurance companies denying coverage -

Malignancy risk in JAK inhibitors -

MACE risk in JAK inhibitors -

Oral azoles for head-and-neck dermatitis -

Luke's PDPC course and the Intermountain Derm Society meeting: https://registration.socio.events/e/idspdpc23/promo-codes/ATTENDEE

Connect with us!

- Web: https://dermaspherepodcast.com/

- Twitter: @DermaspherePC

- Instagram: dermaspherepodcast

- Facebook: https://www.facebook.com/DermaspherePodcast/

- Check out Luke and Michelle’s other podcast, SkinCast! https://healthcare.utah.edu/dermatology/skincast/

Luke and Michelle report no significant conflicts of interest… BUT check out our friends at:

- Kikoxp.com(a social platform for doctors to share knowledge)

- https://www.levelex.com/games/top-derm (A free dermatology game to learn more dermatology!)

168 episoder

#Fitness #Medicine #Luke Johnson